Skip to main content
Equibles
RLAY $18.33 -0.05%
RLAY logo
RLAY · Relay Therapeutics, Inc.
Track RLAY — free

Use RLAY with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RLAY.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.33 -0.01 (-0.05%)
Russell 2000 member Rebalance outlook locked
Market Cap
$4.02B
Shares
219.14M
Volume · Oct 23 1.9M Avg daily vol (3M) 2.75M
All webcasts

Earnings call · FY2022 Q2

Relay Therapeutics, Inc. (RLAY) Q2 2022 Earnings Call

Concluded Aug 4, 2022
Aug 4, 2022 0 turns
Period
FY2022 Q2
Runtime
—
Sources
2 artifacts
Revenue $365,000 -56.8% YoY
Diluted EPS -$0.71
Net income -$76.79M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 4, 2022 10-Q report Filed Aug 4, 2022
Full-screen source Call document

RLAY alerts

Relay Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →